Skip to main content

Advertisement

SpringerLink
Log in

Dominus effect: challenging complications of alemtuzumab-related thyroid autoimmunity

  • Comment
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Scappaticcio L, Castellana M, Virili C, Bellastella G, Centanni M, Cannavò S, Campennì A, Ruggeri RM, Giovanella L, Trimboli P (2019) Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis. J Endocrinol Invest 43:219–229

    Article  Google Scholar 

  2. Devonshire V, Phillips R, Wass H, Da Roza G, Senior P (2018) Monitoring and management of autoimmunity in multiple sclerosis patients treated with alemtuzumab: practical recommendations. J Neurol 265:2494–2505

    Article  CAS  Google Scholar 

  3. Tuohy O, Costelloe L, Hill-Cawthorne G, Bjornson I, Harding K, Robertson N et al (2015) Alemtuzumab treatment of multiple sclerosis: long term safety and efficacy. J Neurol Neurosurg Psychiatry 86:208–215

    Article  Google Scholar 

  4. Pariani N, Willis M, Muller I, Healy S, Nasser T, McGowan A et al (2018) Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features. J Clin Endocrinol Metab 103:3010–3018

    Article  Google Scholar 

  5. Vos XG, Endert E, Zwinderman K, Tijssen JGP, Wiersinga WM (2016) Predicting the risk of recurrence before the start of antithyroid drug therapy in patients with Graves’ hyperthyroidism. J Clin Endocrinol Metab 26:765–769

    Google Scholar 

  6. Bartalena L, Masiello E, Magri F, Veronesi G, Bianconi E, Zerbini F, Gaiti M, Spreafico E, Gallo D, Premoli P, Piantanida E, Tanda ML, Ferrario M, Vitti P, Chiovato L (2016) The phenotype of newly diagnosed Graves’ disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study. J Endocrinol Invest 39:1445–1451

    Article  CAS  Google Scholar 

Download references

Funding

This study was not sponsored.

Author information

Author notes

  1. A. Bianco and T. Nicoletti have contributed equally to this work.

Authors and Affiliations

  1. Istituto di Neurologia, Università Cattolica del Sacro Cuore, Rome, Italy

    Assunta Bianco, Tommaso Nicoletti, Matteo Lucchini & Massimiliano Mirabella

  2. UOC di Neurologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

    Assunta Bianco, Tommaso Nicoletti, Matteo Lucchini & Massimiliano Mirabella

  3. Dipartimento di Chirurgia Endocrina e Metabolica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

    Emanuela Traini

  4. Dipartimento di Chirurgia Endocrina e Metabolica, Università Cattolica del Sacro Cuore, Rome, Italy

    Emanuela Traini

  5. UOC di Malattie Infettive, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

    Paola Del Giacomo

  6. Dipartimento di Endocrinologia, Università Cattolica del Sacro Cuore, Rome, Italy

    Valeria Del Gatto & Carlo A. Rota

  7. UOC di Endocrinologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

    Valeria Del Gatto & Carlo A. Rota

Authors
  1. Assunta Bianco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tommaso Nicoletti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emanuela Traini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paola Del Giacomo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Valeria Del Gatto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Matteo Lucchini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Carlo A. Rota
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Massimiliano Mirabella
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Assunta Bianco.

Ethics declarations

Conflict of interest

The authors report no disclosures.

Research involving human participants and/or animals,

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

Informed consent was obtained by patient.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bianco, A., Nicoletti, T., Traini, E. et al. Dominus effect: challenging complications of alemtuzumab-related thyroid autoimmunity. J Endocrinol Invest 43, 1159–1161 (2020). https://doi.org/10.1007/s40618-020-01204-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-020-01204-w

Keywords

Search

Navigation